Initial Investment in Altavo

We are excited to announce OCCIDENT investing in Altavo and taking the lead in the oversubscribed €5 million Series A round. Altavo is a Dresden-based MedTech start-up with strong ties to the Technical University of Dresden.

Based on non-invasive radar sensing and innovative artificial intelligence algorithms, Altavo is developing an artificial voice with the vision of improving the rehabilitation and quality of life of aphonic and severely voice-impaired patients. The technology can be applied in various fields, such as for cancer patients who have lost their voice due to a laryngectomy or for patients during mechanical ventilation. In addition, Altavo’s technology opens up completely new opportunities in the field of silent communication and human-machine interfaces.

The funds will finance the product development, the pivotal clinical trial and the company’s growth.

More information in the press release under the following link

More about Altavo

Celebrating 10 years of Sandra at OCCIDENT Overview Initial Investment in Chipmetrics
Want to learn more about OCCIDENT?



New OCCIDENT Website

Having sharpened our investor profile and revised our communi­cation, we get to the point: OCCIDENT – The Science Investor.